KR910006424B1 - Method of manufacturing knitted briefs - Google Patents
Method of manufacturing knitted briefs Download PDFInfo
- Publication number
- KR910006424B1 KR910006424B1 KR1019870700355A KR880700355A KR910006424B1 KR 910006424 B1 KR910006424 B1 KR 910006424B1 KR 1019870700355 A KR1019870700355 A KR 1019870700355A KR 880700355 A KR880700355 A KR 880700355A KR 910006424 B1 KR910006424 B1 KR 910006424B1
- Authority
- KR
- South Korea
- Prior art keywords
- blanks
- brief
- knitting
- blank
- cutting
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
내용없음.None.
Description
제1a도는 원형 편성기로부터 제거한 절개하지 않은 허리가 잘록한 튜브의 도식도로서, 제1b도, 제1c도, 제1d도 및 제1e도는 각 위치의 편환구조를 나타낸 것이다.FIG. 1A is a schematic diagram of an uncut incision waist tube removed from a circular knitting machine, and FIGS. 1B, 1C, 1D, and 1E show a ring structure at each position.
제2도는 제1c도에 도시한 편성튜브로부터 제작한 하나의 플렛니트 브리프 블랭키를 펼친 것을 도시한 것이다.FIG. 2 shows the unfolding of one flat knit brief blank made from the knitted tube shown in FIG.
제3도는 제2도의 블랭크를 브리프 형태로 접은 것을 도시한 것이다.3 shows the folding of the blank of FIG. 2 into a brief form.
제4도는 제3도의 블랭크를 박음질(seaming)하여 완성한 브리프를 도시한 것이다.4 shows a brief completed by seaming the blank of FIG.
제5도는 숙녀용 브리프와 아동용 브리프를 제작하기 위한 블랭크를 포함하는 절개되기 전의 허리가 잘록한 튜브를 도시한 것이다.FIG. 5 illustrates a waistlined tube before incision comprising a blank for making a lady's brief and a child's brief.
본 발명은 편성 브리프의 제조방법에 관한 것이다.The present invention relates to a method for producing knitted briefs.
브리프라함은 신체의 허리로부터 가랑이 밑까지를 감싸며, 이 가랑이부의 양측에 다리를 끼울 수 있는 개구가 구비되는 의복의 일종이다.Bripraham is a type of clothing that wraps from the waist of the body to the bottom of the crotch and is provided with openings to fit legs on both sides of the crotch.
영국특허 제1485952호인 제1a도는 전통적인 플랫니트 브리프 블랭크를 도시한 것으로, 이 블랭크는 완성된 브리프의 앞·뒷면을 형성하는 장방형 부분과 그 일단부가 다리를 끼우는 개구를 형성하게 되는 사리꼴 부분 및 가랑이부를 형성하는 연결부로 구성되어 있다.Figure 1a, British Patent No. 1485952, illustrates a traditional flat knit brief blank, which is a rectangular section that forms the front and back sides of the finished brief and a trapezoidal section and crotch, one end of which forms an opening for fitting the leg. It is comprised by the connection part which forms a part.
전통적으로 상기 형태의 블랭크는 평직물의 절단에 의하거나 직선식 편성기(straight-bar knitting machine)상에서 루우프를 전송시킴에 의한 웨일방향(세로 편환방향)의 형성에 의해 제조되었다. 그러나 상기 영국특허는 원형 시임레스 호스기(circualr seamless hose machine)에서 튜브형 시임레스 블랭크를 편성하고, 소정형상의 블랭크를 제조하기 위해 상기 관해 블랭크를 절개하는 방법에 대해 기술하고 있다.Traditionally blanks of this type have been produced by cutting the plain fabric or by forming the wale direction (vertical cyclic direction) by transferring the loops on a straight-bar knitting machine. However, the British patent describes a method of knitting tubular seamless blanks in a circular seamless hose machine and cutting the blanks in order to produce a blank of a desired shape.
넓은 의미에서의 본 발명은 다수의 블랭크가 병렬로 연결되어 튜브형태를 이루는 것을 특징으로 하는 원형편성기상에서의 다수의 브리프 블랭크의 편성방법을 제공하는 것이다.The present invention in a broad sense is to provide a method for knitting a plurality of brief blanks on a circular knitting machine, characterized in that a plurality of blanks are connected in parallel to form a tube.
본 발명의 첫번째 관점은 원형편성기상에서 소정형태의 다수의 브리프 블랭크를 편성하는 방법을 제공하는 것으로서, 이 편성방법은 튜브형태로 병렬연결된 블랭크를 편성하는 단계, 상기 편성기상에서 상기 튜브형태의 블랭크가 편성될 때 상기 상호연결된 블랭크 사이의 연결부를 웨일(세로방향 편환)방향으로 절개하는 단계 및 소정형태의 다수의 브리프 블랭크를 제공하기 위해 연속되는 블랭크를 코스(가로방향 편환)방향으로 절단하는 단계를 포함한다.A first aspect of the present invention provides a method of knitting a plurality of brief blanks of a predetermined shape on a circular knitting machine, the knitting method comprising: forming a tube connected in parallel in the form of tubes, the tube-shaped blank on the knitting machine; Cutting the joints between the interconnected blanks in the direction of the wale (vertical deflection) and cutting the continuous blank in the course (horizontal deflection) direction to provide a plurality of brief blanks of a predetermined type when is formed. It includes.
본 발명의 두번째 관점은 원형 편성기상에서, 소정 형태의 다수의 브리프 블랭크를 편성하는 방법을 제공하는 것으로서, 이 편성방법은 튜브형태로 병렬 연결된 블랭크를 편성하는 단계, 연속 블랭크를 코스방향으로 절단하는 단계, 상기 편성기로부터 상기 튜브형 블랭크를 제거하는 단계, 소정형태의 다수의 브리프 블랭크를 제공하기 위해 상기 연결된 블랭크사이의 연결부를 웨일방향으로 절개하는 단계를 포함한다.A second aspect of the present invention is to provide a method for knitting a plurality of brief blanks of a predetermined shape on a circular knitting machine, which comprises the steps of knitting a parallel connected blank in the form of a tube, and cutting the continuous blank in the course direction. Removing the tubular blank from the knitting machine, and cutting the connection between the connected blanks in the wale direction to provide a plurality of brief blanks of some type.
상기 튜브형 블랭크는 필요에 따라 웨일방향으로 수회에 걸쳐 절개할 수 있으며, 2개의 블랭크로 구성된 튜브일 경우에는 튜브를 납작하게 한 뒤에 통상의 고온 와이어장치를 이용하여 동시에 두 부분의 웨일방향으로 절개를 실시할 수 있다.The tubular blank can be cut several times in the wale direction as needed, and in the case of a tube made of two blanks, the tube is flattened and then cut in two directions at the same time using a common high-temperature wire device. It can be carried out.
이하 첨부한 도면을 참고로 하여 본 발명의 실시예에 대해 설명한다.Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings.
제1c도의 허리가 잘록한 튜브는 전적으로 멀티피드 원형 편성기상에서 로터리 니팅법(rotary knitting)에 의해 편성된다. 이 튜브는 모래 시계형태의 2개의 브리프 블랭크가 연결된 것으로, 도면에서 E, E1및 F, F1은 완성된 브리프의 허리 밴드를 형성하는 부분이다. 상기 두 블랭크를 용이하게 분리하기 위해 Z, Z로 표시한 부분은 통상 3개의 편침(needle)을 생략한다.The waisted tube of FIG. 1C is knitted entirely by rotary knitting on a multifeed circular knitting machine. The tube is connected to two brief blanks in the form of an hourglass, where E, E 1 and F, F 1 form the waist band of the completed brief. In order to easily separate the two blanks, portions indicated by Z and Z generally omit three needles.
먼저, 상기 두 블랭크의 반쪽 허리밴드를 편성하며, 그 편성구조는 제1b도에 도시한 바와 같다. 허리밴드부 E, E1부분은 헬란카사(상표명)(10)로 편성한 184코스의 직물로 구성되며, 리크라사(상표명)(12)가 1×1 니트(knit)/플로트(float)의 상태로 레이드인 되어있다.First, the half waistbands of the two blanks are knitted, and the knitting structure thereof is as shown in FIG. 1B. The waistbands E and E 1 are composed of 184 course fabrics composed of Helankasa (10), and Lycra (trademark) 12 is in a 1 × 1 knit / float state. It has been raided.
다음에 브리프의 몸통부를 편성한다. E, D, B, E1의 넓이는 허리밴드부 E,E1의 넓이와 같고 가랑이부 C, A, C1, A1,의 넓이는 허리밴드부 E, E1의 약 1/3이다. G, G1은 가랑이부의 비대칭 중심이다.Next, the body of the brief is knitted. The width of E, D, B, E 1 is the width of the waist band part E, equal to the width of the E 1 crotch portion C, A, C 1, A 1, is about one-third of the waist band portions E, E 1. G and G 1 are asymmetric centers of the crotch.
E, D, C, G, A, B, E1및 F, D1, C1, G1, A1, B1, F1부분은 모두 헬란카사로 구성된 평편포(plain stitch fabric)로 되어 있다. 제1a도의 D, D1및 B, B1부분은 각각 완성된 브리프의 다리 개구를 형성하며 C, C1및 A, A1은 가랑이부를 형성한다. C, A, G C1,A1,G1부은 제1d도와 같이 헬란카사에 의해 7×1상태로 편성된다. 이 직물은 두개의 평직 웨일(14)가 이격되어 있고 그 사이에 7개의 얼터니트코스(16)개 개재하는 구조로 되어 있다.E, D, C, G, A, B, E 1 and F, D 1 , C 1 , G 1 , A 1 , B 1 , F 1 parts are all made of plain stitch fabric composed of Helankasa have. The portions D, D 1 and B and B 1 in FIG. 1A form the leg openings of the completed briefs, respectively, and C, C 1 and A and A 1 form the crotch portions. The C, A, GC 1 , A 1 , and G 1 parts are knitted in the 7 × 1 state by Helanka as shown in FIG. 1d. The fabric has a structure in which two
CC1및 AA1제1c도에 도시한 가랑이부의 탄력성 구조로서, 이 구조는 제1c도의 구조와 동일하지만 리크라사와 플로팅된 헬란카사(20)을 사용한 점이 다르다.CC 1 and AA 1 As the elastic structure of the crotch portion shown in FIG. 1c, this structure is the same as that of FIG. 1c, but differs in the use of Likrasa and the floated Helanka 20.
상기 두 사(리크라사, 헬란카사)는 넓은 간격의 웨일로 편성(8번째 웨일)되며 개재하는 웨일을 가로질러 임의의 위치에 플로팅된다. 따라서 상기 길게 되어 있는 플로트는 상기 가랑이 부위의 직물을 웨일방향으로 수축시킴으로써 이 부분의 폭(d)은 몸통부의 폭(d1)의 약 1/3이 된다. 마지막으로, E, E1과 유사한 웰트(제1c도에 도시된 구조)가 플레인 런 오프(run-off)부와 편성된다. 상기 런 오프부는 튜브형 허리 밴드부의 단부를 체결하는데 충분한 길이로 함으로써 완성된 튜브의 프레스오프를 용이하게 한다.The two yarns (Likrasa, Helankasa) are knitted into a wide spaced wale (eighth wale) and float in arbitrary positions across the intervening wale. Thus, the elongated float contracts the crotch fabric in the wale direction so that the width d of this portion is about one third of the width d 1 of the trunk portion. Finally, welts similar to E, E 1 (structure shown in FIG. 1C) are combined with the plane run-off portion. The run off portion has a length sufficient to engage the end of the tubular waist band portion to facilitate press off of the finished tube.
상기 튜브의 편성이 완성되면 상기 편성기로부터 튜브를 제거한 다음, 상기 3개의 편침이 생략된 두 절개부분을 하나 이상의 고온 와이어 커터를 사용하는 하나 또는 다수의 절개작업을 통해 절개한다.When the knitting of the tube is completed, the tube is removed from the knitting machine, and then two incisions, in which the three knitting needles are omitted, are cut through one or more cutting operations using one or more high temperature wire cutters.
튜브를 절개한 다음, 완성된 브리프의 다리개구에 해당하는 가장자리를 선 BB1및 DD1를 따라 내측으로 로울링시킨다. 이것은 제1e도에 도시된 구조, 즉 기다란 플로트(16 웨일에 이르는 플로트)의 얼터네이트코스(32)가 편성된 바닥구조의 루우프(34)를 가로질러 웨일(36)까지 플로팅되어 있는 구조에 의해 달성된다. 제1e도에 도시된 바와 같이 웨일(36)의 우측부는 1×1 플로트 스티치(38)의 연속으로 되어 있으며 그 우측부는 절단부이다. 제1e도에 도시한 구조에 있어서, 절개시 웨일(36)의 우측의 루우프에 의해 직물의 가장자리 자체는 롤링되며, 반면에 웨일(36)의 좌측의 플로트 루우프(32)는 직물을 뒤쪽으로 폴딩(fold)시킴으로써 다리개구를 따라 자동적으로 셀비지(selvedge)를 형성시킨다.After the incision is made, the edges corresponding to the leg openings of the finished briefs are rolled inward along lines BB 1 and DD 1 . This is due to the structure shown in FIG. Is achieved. As shown in FIG. 1E, the right side of the
다음에 상기 블랭크를 제3도에 도시한 바와 같이 접은 다음, 오버로크 기계 또는 플랫로크 기계를 사용하여 블랭크의 측면 가장자리를 시밍한다. 제4도는 이렇게 하여 완성한 브리프를 도시한 것이다.The blank is then folded as shown in FIG. 3 and then seamed the side edges of the blank using an overlock machine or a flatlock machine. Figure 4 shows the brief thus completed.
한편, 상기 튜브형 블랭크는 상기 편성기상에서 코스방향으로 절단하고, 편성기로부터 블랭크를 제거한 다음, 웨일방향으로 절개하여 소정형상의 다수의 브리프 블랭크를 제공할 수도 있다.Meanwhile, the tubular blank may be cut in the course direction on the knitting machine, remove the blank from the knitting machine, and then cut in the wale direction to provide a plurality of brief blanks of a predetermined shape.
[예][Yes]
512개의 편침을 구비하는 5.75인치 직경의 원형 편성기에서 제5도에 도시한 튜브형 직물을 편성했다. 본 직물에는 각각 3개의 편침을 생략한 두 부분의 웨일방향의 분리부(22)가 제공되며, 이 분리부의 실(24)은 플로팅되어 있다. 이 분리부(22)는 브리프 블랭크의 칫수의 차를 조절할 수 있도록 직선으로 연장되지 않는다. 상기 분리부 사이의 일부분은 숙녀용 브리프 제작용으로서 320개의 편침을 포함하며, 상기 분리부사이의 타부분은 아동용 브리프 제작용으로서 180개의 편침을 포함한다. 제5도로부터 알 수 있는 바와 같이 숙녀용 브리프의 블랭크나 아동용 브리프의 블랭크의 길이는 동일하다.The tubular fabric shown in FIG. 5 was knitted in a 5.75 inch diameter circular knitting machine with 512 knitting needles. The fabric is provided with a
상기 숙녀용 브리프 제작용 부분과 아동용 브리프 제작용 부분에는 각각 다른 패턴드럼(pattern drum)이 제공된다. 각 패턴드럼은 상기 두 종의 블랭크의 가랑이부(28,30)에 대해 상이한 선침작용을 한다.The patterning drum for the ladies brief and the part for the briefing for children are provided with different pattern drums. Each pattern drum has a different premature action on the
본 브리프 블랭크는 제1a도에 대해 설명했던 방법으로 편했다. 다만 제1a도에서 두 개의 브리프가 동일한 치수였으나 본 예의 브리프는 전술한 바와 같이 그 치수가 상이하게 되었다. 본 튜브는 코스방향으로 분리되어 두 개의 웨일방향 연결 블랭크를 구비한 짧은 튜브를 제공한다. 상기 짧은 튜브를 편성기로부터 제거하고 웨일방향으로 분리하여 제2도에 도시한 숙녀용 및 아동용 브리프 블랭크를 제조한다. 다음에 제3도에 도시한 바와 같이 상기 각 블랭크를 접은 다음 그 가장자리를 오버로크 하여 제4도에 도시한 브리프를 제조한다.This brief blank was comfortable in the manner described for Figure 1a. In FIG. 1A, the two briefs have the same dimensions, but the briefs of the present example have different dimensions as described above. The tube is separated in the course direction to provide a short tube with two wale connection blanks. The short tube is removed from the knitting machine and separated in the wale direction to make the lady's and children's brief blanks shown in FIG. Next, as shown in FIG. 3, the blanks shown in FIG. 4 are manufactured by folding the blanks and then overlocking the edges thereof.
본 발명은 숙녀용 및 아동용 브리프의 제조에만 국한되지 않고, 전술한 5.75인치 편성기상에서 소정의 브리프 치수에 따라 2개의 숙녀용 브리프를 제작하거나 3개의 아동용 브리프를 제작할 수 있다. 두 개의 동일한 브리프를 편성할 경우에는 싱글 패턴드럼 또는 기타의 선침장치(전기선침 장치와 같은)를 사용할 수 있다.The present invention is not limited to the manufacture of ladies 'and children's briefs, but it is possible to produce two ladies' briefs or three children's briefs according to predetermined brief dimensions on the aforementioned 5.75 inch knitting machine. In the case of two identical briefs, single pattern drums or other needle tips (such as electric needle tips) may be used.
본 발명이 영국특허 제1485952호보다 우수한 점은 좁은 작업장내에서 하나의 편성기에 의해서도 많은 수의 브리프를 제작할 수 있다는 점이다.The advantage of the present invention over British Patent No. 1485952 is that a large number of briefs can be produced by a single knitting machine in a narrow workplace.
Claims (9)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8521117 | 1985-08-21 | ||
US89337586A | 1986-08-01 | 1986-08-01 | |
PCT/US1987/001814 WO1988000831A1 (en) | 1986-08-01 | 1987-07-31 | Dna sequences coding for modified factor viii:c and modified factor viii:c-like polypeptides and processes for producing these polypeptides in high yields |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880701557A KR880701557A (en) | 1988-11-03 |
KR910006424B1 true KR910006424B1 (en) | 1991-08-24 |
Family
ID=25401456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870700355A KR910006424B1 (en) | 1985-08-21 | 1986-08-04 | Method of manufacturing knitted briefs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0275305A4 (en) |
JP (1) | JP2525438B2 (en) |
KR (1) | KR910006424B1 (en) |
AU (1) | AU595640B2 (en) |
WO (1) | WO1988000831A1 (en) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
US5595886A (en) * | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
US5451521A (en) * | 1986-05-29 | 1995-09-19 | Genetics Institute, Inc. | Procoagulant proteins |
US6060447A (en) * | 1987-05-19 | 2000-05-09 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
US5171844A (en) * | 1987-06-12 | 1992-12-15 | Gist-Brocades N.W. | Proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
EP0690126B1 (en) * | 1987-06-12 | 2001-11-28 | Baxter Aktiengesellschaft | Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
US6346513B1 (en) | 1987-06-12 | 2002-02-12 | Baxter Trading Gmbh | Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
DE3720246A1 (en) * | 1987-06-19 | 1988-12-29 | Behringwerke Ag | FACTOR VIII: C-LIKE MOLECULE WITH COAGULATION ACTIVITY |
FR2619314B1 (en) * | 1987-08-11 | 1990-06-15 | Transgene Sa | FACTOR VIII ANALOG, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
JPH0387173A (en) * | 1987-09-10 | 1991-04-11 | Teijin Ltd | Preparation of human active natural type factor viii c and transformant using the same |
JPH025890A (en) * | 1988-06-24 | 1990-01-10 | Chemo Sero Therapeut Res Inst | Production of human factor viiic using avian beta-actin promoter |
SE465222C5 (en) * | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | A recombinant human factor VIII derivative and process for its preparation |
US5661008A (en) * | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
CA2078721A1 (en) * | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
DK53792D0 (en) * | 1992-04-24 | 1992-04-24 | Novo Nordisk As | PROCEDURE FOR PRODUCING PROTEINS |
US20020068303A1 (en) | 1994-07-14 | 2002-06-06 | Ruth Laub | Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
EP1038959A1 (en) | 1999-03-17 | 2000-09-27 | Aventis Behring Gesellschaft mit beschränkter Haftung | Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX |
EP1233064A1 (en) | 2001-02-09 | 2002-08-21 | Aventis Behring Gesellschaft mit beschränkter Haftung | Modified factor VIII cDNA and its use for the production of factor VIII |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
DK2393828T3 (en) | 2009-02-03 | 2017-01-23 | Amunix Operating Inc | Extended recombinant polypeptides and compositions comprising same |
US20120263701A1 (en) | 2009-08-24 | 2012-10-18 | Volker Schellenberger | Coagulation factor vii compositions and methods of making and using same |
EP2482841B2 (en) | 2009-10-02 | 2022-09-28 | The Children's Hospital Of Philadelphia | Compositions and methods for enhancing coagulation factor viii function |
BR112012013502A2 (en) | 2009-12-06 | 2017-01-10 | Biogen Idec Hemophilia Inc | "chimeric and hybrid factor viii-fc polypeptides, and methods of using them". |
DK2591099T3 (en) | 2010-07-09 | 2021-02-15 | Bioverativ Therapeutics Inc | CHIMARY COAGULATION FACTORS |
EP3508573A1 (en) | 2010-07-09 | 2019-07-10 | Bioverativ Therapeutics Inc. | Systems for factor viii processing and methods thereof |
EA029045B1 (en) | 2011-07-08 | 2018-02-28 | Байоджен Хемофилия Инк. | Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
EA028914B1 (en) | 2011-07-25 | 2018-01-31 | Байоджен Хемофилия Инк. | Assays to monitor bleeding disorders |
AU2012318292B2 (en) | 2011-10-18 | 2015-08-20 | Csl Limited | Method for improving the stability of purified Factor VIII after reconstitution |
KR102212098B1 (en) | 2012-01-12 | 2021-02-03 | 바이오버라티브 테라퓨틱스 인크. | Chimeric factor viii polypeptides and uses thereof |
ES2700583T3 (en) | 2012-01-12 | 2019-02-18 | Bioverativ Therapeutics Inc | Procedures for reducing immunogenicity against Factor VIII in individuals undergoing Factor VIII therapy |
SG11201404885RA (en) | 2012-02-15 | 2014-09-26 | Amunix Operating Inc | Factor viii compositions and methods of making and using same |
US10370430B2 (en) | 2012-02-15 | 2019-08-06 | Bioverativ Therapeutics Inc. | Recombinant factor VIII proteins |
AU2013270682A1 (en) | 2012-06-08 | 2014-12-11 | Biogen Ma Inc. | Procoagulant compounds |
CA2875247A1 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Chimeric clotting factors |
EP2870250B2 (en) | 2012-07-06 | 2022-06-29 | Bioverativ Therapeutics Inc. | Cell line expressing single chain factor viii polypeptides and uses thereof |
SG11201500045RA (en) | 2012-07-11 | 2015-02-27 | Amunix Operating Inc | Factor viii complex with xten and von willebrand factor protein, and uses thereof |
WO2014018777A2 (en) | 2012-07-25 | 2014-01-30 | Biogen Idec Ma Inc. | Blood factor monitoring assay and uses thereof |
EP2908847B1 (en) | 2012-10-18 | 2022-03-30 | Bioverativ Therapeutics Inc. | Methods of using a fixed dose of a clotting factor |
WO2014070953A1 (en) | 2012-10-30 | 2014-05-08 | Biogen Idec Ma Inc. | Methods of Using FVIII Polypeptide |
DK3889173T3 (en) | 2013-02-15 | 2023-10-09 | Bioverativ Therapeutics Inc | OPTIMIZED FACTOR VIII GENE |
EA201890671A1 (en) | 2013-03-15 | 2019-01-31 | Биовератив Терапьютикс Инк. | DRUGS OF POLYPEPTIDE FACTOR VIII |
EP2968498A4 (en) | 2013-03-15 | 2016-09-07 | Biogen Ma Inc | Factor ix polypeptide formulations |
CN113831415A (en) | 2013-06-28 | 2021-12-24 | 比奥贝拉蒂治疗公司 | Thrombin cleavable linker with XTEN and uses thereof |
EP3875106A1 (en) | 2013-08-08 | 2021-09-08 | Bioverativ Therapeutics Inc. | Purification of chimeric fviii molecules |
US10548953B2 (en) | 2013-08-14 | 2020-02-04 | Bioverativ Therapeutics Inc. | Factor VIII-XTEN fusions and uses thereof |
US10584147B2 (en) | 2013-11-08 | 2020-03-10 | Biovertiv Therapeutics Inc. | Procoagulant fusion compound |
ES2967617T3 (en) | 2013-12-06 | 2024-05-03 | Bioverativ Therapeutics Inc | Population pharmacokinetics tools and their uses |
BR112016015512B1 (en) | 2014-01-10 | 2023-12-19 | Bioverativ Therapeutics Inc | CHIMERICAL PROTEIN, PHARMACEUTICAL COMPOSITION AND ITS USES |
US20160347787A1 (en) | 2014-02-04 | 2016-12-01 | Biogen Ma Inc. | Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications |
CN105017410B (en) * | 2014-04-18 | 2018-06-08 | 北京诺思兰德生物技术股份有限公司 | A kind of B areas excalation type recombinant human blood coagulation factors VIII |
MA40864A (en) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | HYPOTAURINE, GABA, BETA-ALANINE AND CHOLINE FOR THE REGULATION OF THE ACCUMULATION OF RESIDUAL BY-PRODUCTS IN MAMMAL CELL CULTURE PROCESSES |
AU2016301303B2 (en) | 2015-08-03 | 2021-10-07 | Bioverativ Therapeutics Inc. | Factor IX fusion proteins and methods of making and using same |
SG10201913278PA (en) | 2016-02-01 | 2020-02-27 | Bioverativ Therapeutics Inc | Optimized factor viii genes |
CN110520150A (en) | 2016-12-02 | 2019-11-29 | 比奥维拉迪维治疗股份有限公司 | Use the method for chimeric coagulation factor therapies hemophilic arthosis |
EP3548063A1 (en) | 2016-12-02 | 2019-10-09 | Bioverativ Therapeutics Inc. | Methods of inducing immune tolerance to clotting factors |
US20200263196A1 (en) | 2017-09-27 | 2020-08-20 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising active cells |
MX2020008152A (en) | 2018-02-01 | 2020-11-24 | Bioverativ Therapeutics Inc | Use of lentiviral vectors expressing factor viii. |
WO2019195056A1 (en) | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising stem cells |
CA3096038A1 (en) | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Implantable particles and related methods |
SG11202010767SA (en) | 2018-05-18 | 2020-11-27 | Bioverativ Therapeutics Inc | Methods of treating hemophilia a |
WO2020033863A1 (en) | 2018-08-09 | 2020-02-13 | Bioverativ Therapeutics Inc. | Nucleic acid molecules and uses thereof for non-viral gene therapy |
UY38389A (en) | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | IMPLANTABLE DEVICES FOR CELLULAR THERAPY AND RELATED METHODS |
WO2023028456A1 (en) | 2021-08-23 | 2023-03-02 | Bioverativ Therapeutics Inc. | Optimized factor viii genes |
WO2023056331A1 (en) | 2021-09-30 | 2023-04-06 | Bioverativ Therapeutics Inc. | Nucleic acids encoding factor viii polypeptides with reduced immunogenicity |
WO2024081310A1 (en) | 2022-10-11 | 2024-04-18 | Sigilon Therapeutics, Inc. | Engineered cells and implantable elements for treatment of disease |
WO2024081309A1 (en) | 2022-10-11 | 2024-04-18 | Sigilon Therapeutics, Inc. | Engineered cells and implantable elements for treatment of disease |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649132A (en) * | 1983-03-31 | 1987-03-10 | Scripps Clinic And Research Foundation | Treatment of Factor VIII inhibitors |
IE80858B1 (en) * | 1983-03-31 | 1999-04-21 | Scripps Research Inst | New factor viii coagulant polypeptides |
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
EP0150735B2 (en) * | 1984-01-12 | 2004-01-07 | Chiron Corporation | Protein composition exhibiting coagulation activity and method for the preparation thereof |
SE8501050D0 (en) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHEMOPHILIC FACTOR AND METHOD FOR PREPARATION THEREOF |
AU5772886A (en) * | 1985-04-12 | 1986-11-05 | Genetics Institute Inc. | Novel procoagulant proteins |
FI98829C (en) * | 1986-01-27 | 1997-08-25 | Chiron Corp | Process for Preparation of Recombinant Protein Complex with Human Factor VIII: C Activity |
US5451521A (en) * | 1986-05-29 | 1995-09-19 | Genetics Institute, Inc. | Procoagulant proteins |
EP0272304B1 (en) * | 1986-06-24 | 1994-01-26 | Novo Nordisk A/S | A process for producing a coagulation active complex of factor viii fragments |
NO872932L (en) * | 1986-07-18 | 1988-01-19 | Gist Brocades Nv | PROCEDURE FOR THE MANUFACTURE OF PROTEINS WITH FACTOR VIVILITY BY MICROBIAL HOSTS, EXPRESSING VECTORS, HOSTING CELLS, ANTIBIOTICS. |
IL84168A0 (en) * | 1986-10-15 | 1988-03-31 | Rorer Int Overseas | Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same |
-
1986
- 1986-08-04 KR KR1019870700355A patent/KR910006424B1/en not_active Application Discontinuation
-
1987
- 1987-07-31 AU AU78040/87A patent/AU595640B2/en not_active Ceased
- 1987-07-31 WO PCT/US1987/001814 patent/WO1988000831A1/en not_active Application Discontinuation
- 1987-07-31 JP JP62504812A patent/JP2525438B2/en not_active Expired - Lifetime
- 1987-07-31 EP EP19870905356 patent/EP0275305A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPS63503275A (en) | 1988-12-02 |
EP0275305A1 (en) | 1988-07-27 |
AU7804087A (en) | 1988-02-24 |
JP2525438B2 (en) | 1996-08-21 |
WO1988000831A1 (en) | 1988-02-11 |
AU595640B2 (en) | 1990-04-05 |
EP0275305A4 (en) | 1988-11-07 |
KR880701557A (en) | 1988-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910006424B1 (en) | Method of manufacturing knitted briefs | |
US4663946A (en) | Method of manufacturing knitted briefs | |
US4682479A (en) | Seamless knit composite garment blank and method | |
US4527403A (en) | Circular knit panty and method | |
US6192717B1 (en) | Method and tubular blank for making substantially seamless garments | |
EP0037629B1 (en) | Production of knitted garments | |
US2707284A (en) | Method of making garments | |
US3985004A (en) | Knitted briefs | |
US5163306A (en) | Garment blank, brief, and method of making | |
US2962884A (en) | Seamless knit garment and method of making same | |
US3739398A (en) | Panty-type garment and process of making such garment | |
JPH0860404A (en) | Panty garment and its preparation | |
US4048819A (en) | Knitted garments | |
CA1044481A (en) | Knit garment, knit blank therefor and method of making same | |
US4043156A (en) | Method of knitting a garment blank | |
US3109301A (en) | Seamless knit garment having increased width and method of making same | |
US3625029A (en) | Girdle and method | |
US5855123A (en) | Knitted textile fabric having integral seamless elasticated contours, panty blank formed thereof, and fabricating a panty garment therefrom | |
EP0384059B1 (en) | Garment blank and brief | |
GB1586827A (en) | Panty hose | |
US4887439A (en) | Process for manufacturing a semi-finished item for the production of briefs with a circular knitting machine | |
US3808842A (en) | Manufacture of lady{40 s panty hose | |
US3075375A (en) | Fashioned tubular girdle and method of making same | |
KR20060043243A (en) | Knitted underpants with front-side opening and without seams in the crutch and method to manufacture | |
US2919567A (en) | Ribbed fabric construction and method of making same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |